PROACTIVE INFLIXIMAB IS MORE EFFECTIVE THAN VEDOLIZUMAB IN INDUCING FECAL CALPROTECTIN REMISSION IN INFLAMMATORY BOWEL DISEASE

Inês Botto  1     Sérgio Bronze     Inês Rodrigues     Juliana Serrazina     Samuel Raimundo Fernandes     Sonia Bernardo     Ana Rita Gonçalves     Ana Isabel Valente     Paula Moura Santos     Luis Correia     Rui Tato Marinho    
1 Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing